BRIDGEBIO PHARMA, INC.

BBIO US10806X1028

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, acoramidis (AG10), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Annual Performance ¹

2021	2022	2023	2024	2025
-74%	-56%	463%	-32%	0%

Annual Insiders Turnover, USD ²

¹ annual and historical performance metrics are recalculated on a daily basis;
² represents the total value of insider transactions (both buying and selling);

Insider Activity

Person	Price	Shares	Total	Published	Completed
Kumar Neil CEO	51.95 USD	2,300 Sold	119,496 USD	04/09/2025	05/09/2025
Kumar Neil CEO	51.96 USD	2,300 Sold	119,514 USD	04/09/2025	05/09/2025
Kumar Neil CEO	53.80 USD	900 Sold	48,424 USD	04/09/2025	05/09/2025
Kumar Neil CEO	53.16 USD	16,900 Sold	898,450 USD	04/09/2025	05/09/2025
Kumar Neil CEO	53.80 USD	800 Sold	43,040 USD	04/09/2025	05/09/2025
Mccormick Frank	53.16 USD	74,000 Sold	3,933,544 USD	05/09/2025	05/09/2025
Kumar Neil CEO	53.16 USD	16,800 Sold	893,125 USD	04/09/2025	05/09/2025
Kumar Neil CEO	51.16 USD	14,558 Sold	744,739 USD	04/09/2025	04/09/2025
Kumar Neil CEO	51.15 USD	14,525 Sold	742,960 USD	04/09/2025	04/09/2025
Kumar Neil CEO	51.85 USD	5,442 Sold	282,187 USD	04/09/2025	04/09/2025

Load More

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include BRIDGEBIO PHARMA, INC. to your watchlist and receive automatic alerts for upcoming transactions.

Generate

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

• Insider Transaction Amount Distribution
• Insider Trading Seasonality
• Delta Correlation Analysis

 

Historical Performance

1M	3M	6M	1Y	3Y	5Y	All Time
11%	6%	-2%	82%	-9%	0%	2%

Last	52W Low	52W High	All-Time Low	All-Time High	β
55.30	22.35	55.30	5.21	72.35

Company Insiders

Person / Entity	Transactions	Turnover, USD	Average, USD	First	Last
Kumar Neil	47	52,843,377.11	1,124,327.17	17/11/2023	05/09/2025
Mccormick Frank	4	16,985,144.00	4,246,286.00	26/12/2023	05/09/2025
Homcy Charles J	3	13,912,442.76	4,637,480.92	08/08/2025	11/08/2025
Lo Andrew	2	7,699,800.00	3,849,900.00	02/05/2025	02/05/2025
Stephenson Brian C	8	3,755,634.06	469,454.26	17/11/2023	25/02/2025
Trimarchi Thomas	3	2,961,803.47	987,267.82	18/08/2025	21/08/2025
Ellis Andrea	3	2,212,683.00	737,561.00	01/04/2025	05/08/2025
Valantine Hannah	15	1,311,422.89	87,428.19	28/12/2021	26/06/2025
Scott Randal W.	7	314,292.52	44,898.93	01/12/2023	04/06/2024
Apuli Maricel	3	124,458.22	41,486.07	02/05/2025	07/08/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Connected Companies ³

Name	ISIN	Ticker
CareDx, Inc.	US14167L1035	CDNA

³ the firms where the current insiders have executed transactions.

Stock Advanced Metrics

Delta Correlation	subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4	subscribe 🔒

⁴ represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

⁵ a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.